companydata.dkcompanydata.dk

KEMIFARMA Consulting ApS: Financial statements 2021

CVR: 34709955

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -122,398 and a net result of DKK 410,239 compared with DKK 392,334 the year before. Equity in the 2021 report amounted to DKK 3,149,061. The solvency ratio was 99.4%.

Gross Profit
DKK -122,398
Profit/Loss
DKK 410,239
Equity
DKK 3,149,061
Total Assets
DKK 3,168,012

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--122K410K3.1M-
2020--15K392K2.8M-
2019--32K176K2.4M-
2018--23K-79K2.3M-
2017--11K191K2.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like KEMIFARMA Consulting ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

KEMIFARMA Consulting ApS: The 2020 annual report is outApr 29, 2021

KEMIFARMA Consulting ApS has published its annual report for 2020. Gross profit came to DKK -14,663, and the net result was DKK 392,334.

About KEMIFARMA Consulting ApS

KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.

Source: annual report 2025, Danish Business Authority